Abstract

With a view of using the nOPV2 vaccine and in accordance with its mandate, the NITAG initiated an informed opinion on the use of nOPV2 in vaccine responses to outbreaks of cVDPV2.

Recommendation Africa Burkina Faso Poliomyelitis